185 related articles for article (PubMed ID: 28622305)
1. The thrombopoietin/MPL axis is activated in the Gata1
Zingariello M; Sancillo L; Martelli F; Ciaffoni F; Marra M; Varricchio L; Rana RA; Zhao C; Crispino JD; Migliaccio AR
Blood Cancer J; 2017 Jun; 7(6):e572. PubMed ID: 28622305
[TBL] [Abstract][Full Text] [Related]
2. Novel targets to cure primary myelofibrosis from studies on Gata1
Zingariello M; Martelli F; Verachi P; Bardelli C; Gobbo F; Mazzarini M; Migliaccio AR
IUBMB Life; 2020 Jan; 72(1):131-141. PubMed ID: 31749302
[TBL] [Abstract][Full Text] [Related]
3. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
[TBL] [Abstract][Full Text] [Related]
5. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
[TBL] [Abstract][Full Text] [Related]
6. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.
Migliaccio AR; Martelli F; Verrucci M; Migliaccio G; Vannucchi AM; Ni H; Xu M; Jiang Y; Nakamoto B; Papayannopoulou T; Hoffman R
Exp Hematol; 2008 Feb; 36(2):158-71. PubMed ID: 18206727
[TBL] [Abstract][Full Text] [Related]
7. Captopril mitigates splenomegaly and myelofibrosis in the Gata1
Corey SJ; Jha J; McCart EA; Rittase WB; George J; Mattapallil JJ; Mehta H; Ognoon M; Bylicky MA; Summers TA; Day RM
J Cell Mol Med; 2018 Sep; 22(9):4274-4282. PubMed ID: 29971909
[TBL] [Abstract][Full Text] [Related]
8. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
9. Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
Leukemia; 2017 Dec; 31(12):2709-2716. PubMed ID: 28386106
[TBL] [Abstract][Full Text] [Related]
10. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
[TBL] [Abstract][Full Text] [Related]
11. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.
Yan XQ; Lacey D; Hill D; Chen Y; Fletcher F; Hawley RG; McNiece IK
Blood; 1996 Jul; 88(2):402-9. PubMed ID: 8695786
[TBL] [Abstract][Full Text] [Related]
12. Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in
Zingariello M; Verachi P; Gobbo F; Martelli F; Falchi M; Mazzarini M; Valeri M; Sarli G; Marinaccio C; Melo-Cardenas J; Crispino JD; Migliaccio AR
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204735
[TBL] [Abstract][Full Text] [Related]
13. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
[TBL] [Abstract][Full Text] [Related]
14. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
[TBL] [Abstract][Full Text] [Related]
15. CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin.
Verrucci M; Pancrazzi A; Aracil M; Martelli F; Guglielmelli P; Zingariello M; Ghinassi B; D'Amore E; Jimeno J; Vannucchi AM; Migliaccio AR
J Cell Physiol; 2010 Nov; 225(2):490-9. PubMed ID: 20458749
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
[TBL] [Abstract][Full Text] [Related]
17. Myelofibrosis: experimental models and human studies.
Taskin AL; Cohen-Solal K; Le Couedic JP; Abina MA; Villeval JL; Debili N; Casadevall N; Vainchenker W; Wendling F
Stem Cells; 1998; 16 Suppl 2():155-64. PubMed ID: 11012187
[TBL] [Abstract][Full Text] [Related]
18. Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.
Zetterberg E; Verrucci M; Martelli F; Zingariello M; Sancillo L; D'Amore E; Rana RA; Migliaccio AR
Platelets; 2014; 25(7):539-47. PubMed ID: 24176039
[TBL] [Abstract][Full Text] [Related]
19. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]